How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
about
The psychological side effects of acebutolol and atenololChanges in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasmaEffects of selective β1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsisNewer beta blockers and the treatment of hypertension.Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.The role of stress and the sympathetic nervous system in hypertension and ischemic heart disease: advantages of therapy with beta-receptor blockers.Central nervous system mechanisms in blood pressure control.Is the ISA of pindolol beta 2-adrenoceptor selective?Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma.Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles.
P2860
Q28367061-73974529-0747-48A9-B47D-74F91BC6B5B4Q33389320-2998A8D8-A1E0-431B-B2C3-E491A3FB8371Q34447485-8A8AF162-27B6-4D71-B5E4-95FEC48A037FQ34621835-47F0820C-09A8-435D-B2AB-9F4BE60B087EQ34670866-225B2423-69D6-4A03-95AA-277172473C45Q36514083-0993604A-5E12-4A9F-8CD3-85BC7DC08CBBQ37599401-E1EC066C-79B2-46D3-830F-2E31C927DB6EQ38074311-AF4B46FF-56CA-4A59-82E0-83BDD9A66ADEQ39285079-3FF47A43-2353-487A-85AC-EF1AE7432318Q39398904-CB58C95C-9221-4CC0-87FE-114DAC1555AAQ39466493-CF1A733D-CA54-45DF-B4E0-D70F7D5F2165Q42074189-884C0D69-9AB4-4542-8480-37DEDEEEC35BQ42108375-AE29FBF6-65C5-4033-9B46-AFF7DBE86109Q43094461-DA1C9D7B-B026-47DB-A5D0-E7E4AC22EC63Q43228931-46594EA3-0D0B-40E4-97E5-08083B1405D9Q43261907-61782EB8-0826-4C2D-96BB-8B85015DF730Q47712667-BFB5B5D7-72CB-4F16-B2B7-86A0F5CAE463
P2860
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@en
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@nl
type
label
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@en
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@nl
prefLabel
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@en
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@nl
P2860
P1476
How intrinsic sympathomimetic ...... ir antihypertensive mechanism.
@en
P2093
Man in 't Veld AJ
Schalekamp MA
P2860
P304
P356
10.1111/J.1365-2125.1982.TB01922.X
P407
P433
P577
1982-01-01T00:00:00Z